Discontinuation report AXERT 6.25MG
Report ID | 27333 |
Drug Identification Number | 02248128 |
Brand name | AXERT 6.25MG |
Common or Proper name | AXERT |
Company Name | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ALMOTRIPTAN |
Strength(s) | 6.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 6 TABLETS |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-10-27 |
Actual discontinuation date | 2017-10-27 |
Remaining supply date | 2017-10-27 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | All stock has been depleted. |
Company comments | J&J North American decision to exit the business. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 88 MCNABB STREET MARKHAM, ONTARIO CANADA L3R 5L2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-10-27 | English | Compare |
v2 | 2017-10-27 | English | Compare |
v3 | 2017-10-27 | English | Compare |
v4 | 2017-10-27 | French | Compare |
v5 | 2017-10-28 | English | Compare |
Showing 1 to 5 of 5